The FDA and the CDC greenlight booster shots of Pfizer-BioNTech's Covid vaccine for 16-and 17-year-olds
On Thursday, the FDA announced that it is expanding the emergency use authorization of the Covid vaccine developed by Pfizer & BioNTech to allow for booster shots in 16 and 17-year-olds. The decision followsThere’s been a renewed urgency for booster shots in the face of rising Covid cases worldwide as well as the spread of the omicron variant.
Pfizer CEO Albert Bourla priased the FDA’s decision in a statement. “Today’s decision by the FDA to further expand the Emergency Use Authorization of a booster dose of our COVID-19 vaccine is a critical milestone as we continue to stay vigilant in addressing the virus.”
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA authorizes Pfizer/BioNTech Covid-19 vaccine boosters for 16- and 17-year-oldsThe US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17. It's the first Covid-19 vaccine booster authorized for this age group in the United States.
Weiterlesen »
FDA Expands Pfizer COVID-19 Booster To 16- And 17-Year-OldsThe U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer’s vaccine.
Weiterlesen »
FDA authorizes Pfizer Covid booster for 16-, 17-year-oldsThe FDA authorized a booster dose of the Pfizer-BioNTech Covid-19 vaccine for 16- and 17-year-olds, giving those teens access to the shots as the Omicron variant spreads worldwide
Weiterlesen »
US expands Pfizer COVID boosters, opens extra dose to age 16U.S. health authorities again expanded the nation's booster campaign Thursday, opening extra doses of Pfizer’s COVID-19 vaccine to several million 16- and 17-year-olds. The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new omicron variant. On Thursday, the Food and Drug Administration gave emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech — once they're six months past their last dose.
Weiterlesen »
FDA clears first Covid antibody treatment for immunocompromised before exposureThe Food and Drug Administration authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus.
Weiterlesen »
FDA clears first Covid antibody treatment for immunocompromised before exposureFDA authorizes for emergency use the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus.
Weiterlesen »